The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Thyroid Eye Disease Treatments Market Research Report 2025
Synopsis
Thyroid eye disease is the inflammation of the eye muscles, eyelids, tear glands and fatty tissues behind the eye. The inflammation leads to swelling of the eye, eyes and eyelids become red and eye ca be pushed forward. The movement of the eye also affects, as both eyes do not move in sync which may result in the double vision. Thyroid eye disease also known as Graves’ Orbitopathy or Ophthalmopathy which is an autoimmune condition, this condition often affects thyroid gland and makes it hyperactive in most of the cases. The thyroid eye disease can affect anybody whose thyroid gland is overactive or underactive or even functioning normally. Around 25% of people with graves’ disease can develop thyroid eye disease.
The global Thyroid Eye Disease Treatments market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Thyroid Eye Disease Treatments, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thyroid Eye Disease Treatments.
Report Scope
The Thyroid Eye Disease Treatments market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thyroid Eye Disease Treatments market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thyroid Eye Disease Treatments companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bausch And Lomb Inc
Kala Pharmaceuticals Inc
Pharmos Corp
Hi-Tech Pharmacal Co Inc
Allergan plc
Novartis AG
Eyevance Pharmaceuticals LLC
Pfizer Inc
Horizon Therapeutics plc
Segment by Type
Medication
Radioactive Iodine Therapy
Surgery
Segment by Application
Surgery Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Thyroid Eye Disease Treatments companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Thyroid eye disease is the inflammation of the eye muscles, eyelids, tear glands and fatty tissues behind the eye. The inflammation leads to swelling of the eye, eyes and eyelids become red and eye ca be pushed forward. The movement of the eye also affects, as both eyes do not move in sync which may result in the double vision. Thyroid eye disease also known as Graves’ Orbitopathy or Ophthalmopathy which is an autoimmune condition, this condition often affects thyroid gland and makes it hyperactive in most of the cases. The thyroid eye disease can affect anybody whose thyroid gland is overactive or underactive or even functioning normally. Around 25% of people with graves’ disease can develop thyroid eye disease.
The global Thyroid Eye Disease Treatments market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Thyroid Eye Disease Treatments, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thyroid Eye Disease Treatments.
Report Scope
The Thyroid Eye Disease Treatments market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thyroid Eye Disease Treatments market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thyroid Eye Disease Treatments companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bausch And Lomb Inc
Kala Pharmaceuticals Inc
Pharmos Corp
Hi-Tech Pharmacal Co Inc
Allergan plc
Novartis AG
Eyevance Pharmaceuticals LLC
Pfizer Inc
Horizon Therapeutics plc
Segment by Type
Medication
Radioactive Iodine Therapy
Surgery
Segment by Application
Surgery Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Thyroid Eye Disease Treatments companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Thyroid Eye Disease Treatments Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Medication
1.2.3 Radioactive Iodine Therapy
1.2.4 Surgery
1.3 Market by Application
1.3.1 Global Thyroid Eye Disease Treatments Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Surgery Hospital Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Thyroid Eye Disease Treatments Market Perspective (2019-2030)
2.2 Thyroid Eye Disease Treatments Growth Trends by Region
2.2.1 Global Thyroid Eye Disease Treatments Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Thyroid Eye Disease Treatments Historic Market Size by Region (2019-2024)
2.2.3 Thyroid Eye Disease Treatments Forecasted Market Size by Region (2025-2030)
2.3 Thyroid Eye Disease Treatments Market Dynamics
2.3.1 Thyroid Eye Disease Treatments Industry Trends
2.3.2 Thyroid Eye Disease Treatments Market Drivers
2.3.3 Thyroid Eye Disease Treatments Market Challenges
2.3.4 Thyroid Eye Disease Treatments Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Thyroid Eye Disease Treatments Players by Revenue
3.1.1 Global Top Thyroid Eye Disease Treatments Players by Revenue (2019-2024)
3.1.2 Global Thyroid Eye Disease Treatments Revenue Market Share by Players (2019-2024)
3.2 Global Thyroid Eye Disease Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Thyroid Eye Disease Treatments Revenue
3.4 Global Thyroid Eye Disease Treatments Market Concentration Ratio
3.4.1 Global Thyroid Eye Disease Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Thyroid Eye Disease Treatments Revenue in 2023
3.5 Thyroid Eye Disease Treatments Key Players Head office and Area Served
3.6 Key Players Thyroid Eye Disease Treatments Product Solution and Service
3.7 Date of Enter into Thyroid Eye Disease Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Thyroid Eye Disease Treatments Breakdown Data by Type
4.1 Global Thyroid Eye Disease Treatments Historic Market Size by Type (2019-2024)
4.2 Global Thyroid Eye Disease Treatments Forecasted Market Size by Type (2025-2030)
5 Thyroid Eye Disease Treatments Breakdown Data by Application
5.1 Global Thyroid Eye Disease Treatments Historic Market Size by Application (2019-2024)
5.2 Global Thyroid Eye Disease Treatments Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Thyroid Eye Disease Treatments Market Size (2019-2030)
6.2 North America Thyroid Eye Disease Treatments Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Thyroid Eye Disease Treatments Market Size by Country (2019-2024)
6.4 North America Thyroid Eye Disease Treatments Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Thyroid Eye Disease Treatments Market Size (2019-2030)
7.2 Europe Thyroid Eye Disease Treatments Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Thyroid Eye Disease Treatments Market Size by Country (2019-2024)
7.4 Europe Thyroid Eye Disease Treatments Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Thyroid Eye Disease Treatments Market Size (2019-2030)
8.2 Asia-Pacific Thyroid Eye Disease Treatments Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Thyroid Eye Disease Treatments Market Size by Region (2019-2024)
8.4 Asia-Pacific Thyroid Eye Disease Treatments Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Thyroid Eye Disease Treatments Market Size (2019-2030)
9.2 Latin America Thyroid Eye Disease Treatments Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Thyroid Eye Disease Treatments Market Size by Country (2019-2024)
9.4 Latin America Thyroid Eye Disease Treatments Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Thyroid Eye Disease Treatments Market Size (2019-2030)
10.2 Middle East & Africa Thyroid Eye Disease Treatments Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Thyroid Eye Disease Treatments Market Size by Country (2019-2024)
10.4 Middle East & Africa Thyroid Eye Disease Treatments Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch And Lomb Inc
11.1.1 Bausch And Lomb Inc Company Detail
11.1.2 Bausch And Lomb Inc Business Overview
11.1.3 Bausch And Lomb Inc Thyroid Eye Disease Treatments Introduction
11.1.4 Bausch And Lomb Inc Revenue in Thyroid Eye Disease Treatments Business (2019-2024)
11.1.5 Bausch And Lomb Inc Recent Development
11.2 Kala Pharmaceuticals Inc
11.2.1 Kala Pharmaceuticals Inc Company Detail
11.2.2 Kala Pharmaceuticals Inc Business Overview
11.2.3 Kala Pharmaceuticals Inc Thyroid Eye Disease Treatments Introduction
11.2.4 Kala Pharmaceuticals Inc Revenue in Thyroid Eye Disease Treatments Business (2019-2024)
11.2.5 Kala Pharmaceuticals Inc Recent Development
11.3 Pharmos Corp
11.3.1 Pharmos Corp Company Detail
11.3.2 Pharmos Corp Business Overview
11.3.3 Pharmos Corp Thyroid Eye Disease Treatments Introduction
11.3.4 Pharmos Corp Revenue in Thyroid Eye Disease Treatments Business (2019-2024)
11.3.5 Pharmos Corp Recent Development
11.4 Hi-Tech Pharmacal Co Inc
11.4.1 Hi-Tech Pharmacal Co Inc Company Detail
11.4.2 Hi-Tech Pharmacal Co Inc Business Overview
11.4.3 Hi-Tech Pharmacal Co Inc Thyroid Eye Disease Treatments Introduction
11.4.4 Hi-Tech Pharmacal Co Inc Revenue in Thyroid Eye Disease Treatments Business (2019-2024)
11.4.5 Hi-Tech Pharmacal Co Inc Recent Development
11.5 Allergan plc
11.5.1 Allergan plc Company Detail
11.5.2 Allergan plc Business Overview
11.5.3 Allergan plc Thyroid Eye Disease Treatments Introduction
11.5.4 Allergan plc Revenue in Thyroid Eye Disease Treatments Business (2019-2024)
11.5.5 Allergan plc Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Detail
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Thyroid Eye Disease Treatments Introduction
11.6.4 Novartis AG Revenue in Thyroid Eye Disease Treatments Business (2019-2024)
11.6.5 Novartis AG Recent Development
11.7 Eyevance Pharmaceuticals LLC
11.7.1 Eyevance Pharmaceuticals LLC Company Detail
11.7.2 Eyevance Pharmaceuticals LLC Business Overview
11.7.3 Eyevance Pharmaceuticals LLC Thyroid Eye Disease Treatments Introduction
11.7.4 Eyevance Pharmaceuticals LLC Revenue in Thyroid Eye Disease Treatments Business (2019-2024)
11.7.5 Eyevance Pharmaceuticals LLC Recent Development
11.8 Pfizer Inc
11.8.1 Pfizer Inc Company Detail
11.8.2 Pfizer Inc Business Overview
11.8.3 Pfizer Inc Thyroid Eye Disease Treatments Introduction
11.8.4 Pfizer Inc Revenue in Thyroid Eye Disease Treatments Business (2019-2024)
11.8.5 Pfizer Inc Recent Development
11.9 Horizon Therapeutics plc
11.9.1 Horizon Therapeutics plc Company Detail
11.9.2 Horizon Therapeutics plc Business Overview
11.9.3 Horizon Therapeutics plc Thyroid Eye Disease Treatments Introduction
11.9.4 Horizon Therapeutics plc Revenue in Thyroid Eye Disease Treatments Business (2019-2024)
11.9.5 Horizon Therapeutics plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Thyroid Eye Disease Treatments Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Medication
Table 3. Key Players of Radioactive Iodine Therapy
Table 4. Key Players of Surgery
Table 5. Global Thyroid Eye Disease Treatments Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Thyroid Eye Disease Treatments Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Thyroid Eye Disease Treatments Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Thyroid Eye Disease Treatments Market Share by Region (2019-2024)
Table 9. Global Thyroid Eye Disease Treatments Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Thyroid Eye Disease Treatments Market Share by Region (2025-2030)
Table 11. Thyroid Eye Disease Treatments Market Trends
Table 12. Thyroid Eye Disease Treatments Market Drivers
Table 13. Thyroid Eye Disease Treatments Market Challenges
Table 14. Thyroid Eye Disease Treatments Market Restraints
Table 15. Global Thyroid Eye Disease Treatments Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Thyroid Eye Disease Treatments Market Share by Players (2019-2024)
Table 17. Global Top Thyroid Eye Disease Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thyroid Eye Disease Treatments as of 2023)
Table 18. Ranking of Global Top Thyroid Eye Disease Treatments Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Thyroid Eye Disease Treatments Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Thyroid Eye Disease Treatments Product Solution and Service
Table 22. Date of Enter into Thyroid Eye Disease Treatments Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Thyroid Eye Disease Treatments Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Thyroid Eye Disease Treatments Revenue Market Share by Type (2019-2024)
Table 26. Global Thyroid Eye Disease Treatments Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Thyroid Eye Disease Treatments Revenue Market Share by Type (2025-2030)
Table 28. Global Thyroid Eye Disease Treatments Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Thyroid Eye Disease Treatments Revenue Market Share by Application (2019-2024)
Table 30. Global Thyroid Eye Disease Treatments Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Thyroid Eye Disease Treatments Revenue Market Share by Application (2025-2030)
Table 32. North America Thyroid Eye Disease Treatments Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Thyroid Eye Disease Treatments Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Thyroid Eye Disease Treatments Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Thyroid Eye Disease Treatments Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Thyroid Eye Disease Treatments Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Thyroid Eye Disease Treatments Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Thyroid Eye Disease Treatments Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Thyroid Eye Disease Treatments Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Thyroid Eye Disease Treatments Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Thyroid Eye Disease Treatments Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Thyroid Eye Disease Treatments Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Thyroid Eye Disease Treatments Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Thyroid Eye Disease Treatments Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Thyroid Eye Disease Treatments Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Thyroid Eye Disease Treatments Market Size by Country (2025-2030) & (US$ Million)
Table 47. Bausch And Lomb Inc Company Detail
Table 48. Bausch And Lomb Inc Business Overview
Table 49. Bausch And Lomb Inc Thyroid Eye Disease Treatments Product
Table 50. Bausch And Lomb Inc Revenue in Thyroid Eye Disease Treatments Business (2019-2024) & (US$ Million)
Table 51. Bausch And Lomb Inc Recent Development
Table 52. Kala Pharmaceuticals Inc Company Detail
Table 53. Kala Pharmaceuticals Inc Business Overview
Table 54. Kala Pharmaceuticals Inc Thyroid Eye Disease Treatments Product
Table 55. Kala Pharmaceuticals Inc Revenue in Thyroid Eye Disease Treatments Business (2019-2024) & (US$ Million)
Table 56. Kala Pharmaceuticals Inc Recent Development
Table 57. Pharmos Corp Company Detail
Table 58. Pharmos Corp Business Overview
Table 59. Pharmos Corp Thyroid Eye Disease Treatments Product
Table 60. Pharmos Corp Revenue in Thyroid Eye Disease Treatments Business (2019-2024) & (US$ Million)
Table 61. Pharmos Corp Recent Development
Table 62. Hi-Tech Pharmacal Co Inc Company Detail
Table 63. Hi-Tech Pharmacal Co Inc Business Overview
Table 64. Hi-Tech Pharmacal Co Inc Thyroid Eye Disease Treatments Product
Table 65. Hi-Tech Pharmacal Co Inc Revenue in Thyroid Eye Disease Treatments Business (2019-2024) & (US$ Million)
Table 66. Hi-Tech Pharmacal Co Inc Recent Development
Table 67. Allergan plc Company Detail
Table 68. Allergan plc Business Overview
Table 69. Allergan plc Thyroid Eye Disease Treatments Product
Table 70. Allergan plc Revenue in Thyroid Eye Disease Treatments Business (2019-2024) & (US$ Million)
Table 71. Allergan plc Recent Development
Table 72. Novartis AG Company Detail
Table 73. Novartis AG Business Overview
Table 74. Novartis AG Thyroid Eye Disease Treatments Product
Table 75. Novartis AG Revenue in Thyroid Eye Disease Treatments Business (2019-2024) & (US$ Million)
Table 76. Novartis AG Recent Development
Table 77. Eyevance Pharmaceuticals LLC Company Detail
Table 78. Eyevance Pharmaceuticals LLC Business Overview
Table 79. Eyevance Pharmaceuticals LLC Thyroid Eye Disease Treatments Product
Table 80. Eyevance Pharmaceuticals LLC Revenue in Thyroid Eye Disease Treatments Business (2019-2024) & (US$ Million)
Table 81. Eyevance Pharmaceuticals LLC Recent Development
Table 82. Pfizer Inc Company Detail
Table 83. Pfizer Inc Business Overview
Table 84. Pfizer Inc Thyroid Eye Disease Treatments Product
Table 85. Pfizer Inc Revenue in Thyroid Eye Disease Treatments Business (2019-2024) & (US$ Million)
Table 86. Pfizer Inc Recent Development
Table 87. Horizon Therapeutics plc Company Detail
Table 88. Horizon Therapeutics plc Business Overview
Table 89. Horizon Therapeutics plc Thyroid Eye Disease Treatments Product
Table 90. Horizon Therapeutics plc Revenue in Thyroid Eye Disease Treatments Business (2019-2024) & (US$ Million)
Table 91. Horizon Therapeutics plc Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Thyroid Eye Disease Treatments Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Thyroid Eye Disease Treatments Market Share by Type: 2023 VS 2030
Figure 3. Medication Features
Figure 4. Radioactive Iodine Therapy Features
Figure 5. Surgery Features
Figure 6. Global Thyroid Eye Disease Treatments Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Thyroid Eye Disease Treatments Market Share by Application: 2023 VS 2030
Figure 8. Surgery Hospital Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Thyroid Eye Disease Treatments Report Years Considered
Figure 12. Global Thyroid Eye Disease Treatments Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Thyroid Eye Disease Treatments Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Thyroid Eye Disease Treatments Market Share by Region: 2023 VS 2030
Figure 15. Global Thyroid Eye Disease Treatments Market Share by Players in 2023
Figure 16. Global Top Thyroid Eye Disease Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thyroid Eye Disease Treatments as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Thyroid Eye Disease Treatments Revenue in 2023
Figure 18. North America Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Thyroid Eye Disease Treatments Market Share by Country (2019-2030)
Figure 20. United States Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Thyroid Eye Disease Treatments Market Share by Country (2019-2030)
Figure 24. Germany Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Thyroid Eye Disease Treatments Market Share by Region (2019-2030)
Figure 32. China Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Thyroid Eye Disease Treatments Market Share by Country (2019-2030)
Figure 40. Mexico Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Thyroid Eye Disease Treatments Market Share by Country (2019-2030)
Figure 44. Turkey Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Thyroid Eye Disease Treatments Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Bausch And Lomb Inc Revenue Growth Rate in Thyroid Eye Disease Treatments Business (2019-2024)
Figure 47. Kala Pharmaceuticals Inc Revenue Growth Rate in Thyroid Eye Disease Treatments Business (2019-2024)
Figure 48. Pharmos Corp Revenue Growth Rate in Thyroid Eye Disease Treatments Business (2019-2024)
Figure 49. Hi-Tech Pharmacal Co Inc Revenue Growth Rate in Thyroid Eye Disease Treatments Business (2019-2024)
Figure 50. Allergan plc Revenue Growth Rate in Thyroid Eye Disease Treatments Business (2019-2024)
Figure 51. Novartis AG Revenue Growth Rate in Thyroid Eye Disease Treatments Business (2019-2024)
Figure 52. Eyevance Pharmaceuticals LLC Revenue Growth Rate in Thyroid Eye Disease Treatments Business (2019-2024)
Figure 53. Pfizer Inc Revenue Growth Rate in Thyroid Eye Disease Treatments Business (2019-2024)
Figure 54. Horizon Therapeutics plc Revenue Growth Rate in Thyroid Eye Disease Treatments Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
